EN
বাং
Clonipres
Tablet
🧬 Clonidine Hydrochloride
🏭 Navana Pharmaceuticals Ltd.
GENERIC NAME
Clonidine Hydrochloride
MANUFACTURER
Navana Pharmaceuticals Ltd.
UNIT PRICE
Unit Price: ৳ 10.00 (6 x 10: ৳ 600.00) Strip Price: ৳ 100.00
Indications
Pharmacology
Dosage & Administration
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Storage Conditions
Indications
নির্দেশনা
Clonipres is indicated in the treatment of hypertension. It may be employed alone or concomitantly with other anti-hypertensive agent. Clonipres is also indicated for the treatment of menopausal flushing, opioid withdrawal & alcohol withdrawal syndrome. Clonipres extended release tablet is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy.
Pharmacology
ফার্মাকোলজি
Clonipres is indicated in the treatment of hypertension. It may be employed alone or concomitantly with other anti-hypertensive agent. Clonipres is also indicated for the treatment of menopausal flushing, opioid withdrawal & alcohol withdrawal syndrome. Clonipres extended release tablet is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy.
Dosage & Administration
মাত্রা ও ব্যবহারবিধি
Clonipres is indicated in the treatment of hypertension. It may be employed alone or concomitantly with other anti-hypertensive agent. Clonipres is also indicated for the treatment of menopausal flushing, opioid withdrawal & alcohol withdrawal syndrome. Clonipres extended release tablet is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy.
Interaction
মিথস্ক্রিয়া
Clonipres is indicated in the treatment of hypertension. It may be employed alone or concomitantly with other anti-hypertensive agent. Clonipres is also indicated for the treatment of menopausal flushing, opioid withdrawal & alcohol withdrawal syndrome. Clonipres extended release tablet is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy.
Contraindications
প্রতিনির্দেশনা
Clonipres is indicated in the treatment of hypertension. It may be employed alone or concomitantly with other anti-hypertensive agent. Clonipres is also indicated for the treatment of menopausal flushing, opioid withdrawal & alcohol withdrawal syndrome. Clonipres extended release tablet is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy.
Side Effects
পার্শ্ব প্রতিক্রিয়া
Clonipres is indicated in the treatment of hypertension. It may be employed alone or concomitantly with other anti-hypertensive agent. Clonipres is also indicated for the treatment of menopausal flushing, opioid withdrawal & alcohol withdrawal syndrome. Clonipres extended release tablet is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy.
Pregnancy & Lactation
গর্ভাবস্থায় ও স্তন্যদানকালে
Clonipres is indicated in the treatment of hypertension. It may be employed alone or concomitantly with other anti-hypertensive agent. Clonipres is also indicated for the treatment of menopausal flushing, opioid withdrawal & alcohol withdrawal syndrome. Clonipres extended release tablet is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy.
Precautions & Warnings
সতর্কতা
Clonipres is indicated in the treatment of hypertension. It may be employed alone or concomitantly with other anti-hypertensive agent. Clonipres is also indicated for the treatment of menopausal flushing, opioid withdrawal & alcohol withdrawal syndrome. Clonipres extended release tablet is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy.
Storage Conditions
সংরক্ষণ
Clonipres is indicated in the treatment of hypertension. It may be employed alone or concomitantly with other anti-hypertensive agent. Clonipres is also indicated for the treatment of menopausal flushing, opioid withdrawal & alcohol withdrawal syndrome. Clonipres extended release tablet is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy.